A Theoretical Paradigm for Evaluating Risk-Benefit of Status Epilepticus Treatment

J Clin Neurophysiol. 2020 Sep;37(5):385-392. doi: 10.1097/WNP.0000000000000753.

Abstract

Aggressive treatment of status epilepticus with anesthetic drugs can provide rapid seizure control, but it might lead to serious medical complications and worse outcomes. Using a decision analysis approach, this concise review provides a framework for individualized decision making about aggressive and nonaggressive treatment in status epilepticus. The authors propose and review the most relevant parameters guiding the risk-benefit analysis of treatment aggressiveness in status epilepticus and present real-world-based case examples to illustrate how these tools could be used at the bedside and serve to guide future research in refractory status epilepticus treatment.

Publication types

  • Review

MeSH terms

  • Anesthetics / adverse effects
  • Anesthetics / therapeutic use*
  • Anticonvulsants / adverse effects
  • Anticonvulsants / therapeutic use*
  • Humans
  • Risk Assessment
  • Seizures / diagnosis
  • Seizures / therapy
  • Status Epilepticus / diagnosis*
  • Status Epilepticus / therapy*
  • Treatment Outcome

Substances

  • Anesthetics
  • Anticonvulsants